Clinical trial Recruiting at 1 site Interventional Ages 65 to 75

Effects of dietary fatty acids on brain function in older adults

Official title: Fatty Acid Modulation of Brain Function in Older Adults

Run by University of Vermont · NCT06192407 · Data updated 2026-11-12

This study tests if changing the types of fats in the diet can help improve brain function in healthy older adults aged 65-75.

Quick facts

Study typeInterventional
Ages65 Years to 75 Years
SexAll
Enrollment60 (estimated)
SponsorUniversity of Vermont
Academic / other
Locations1 site (Burlington, Vermont)
StatusRecruiting
StartedApril 15, 2024
Main results expectedJuly 30, 2028
Study endsOctober 31, 2028
Registry record updatedNovember 4, 2026
Trial IDNCT06192407 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are healthy men and women aged 65-75 years with normal cognitive function.

Probably not a fit

Patients with significant cognitive impairment or those on certain medications may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study investigates how different dietary fatty acid compositions affect brain functioning in healthy older adults aged 65-75 years. Participants will follow two experimental diets with varying ratios of palmitic acid and oleic acid, preceded by a low-fat control diet. The study employs a crossover design, allowing each participant to experience both diets in a randomized order over a four-week period. The research aims to determine if reducing saturated fat intake can lead to improvements in cognitive function.

Why it matters

Potential benefit: If successful, this study could lead to dietary recommendations that enhance cognitive health in older adults.

How similar studies have gone: Previous studies have indicated that dietary changes can positively impact cognition, suggesting potential success for this approach.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Men and women age range 65-75 years
* Normal cognition (see Research Strategy for details on cognitive assessments)
* "Healthy" (body mass index (BMI) of 20-40 kg/m2)

Exclusion Criteria:

* Significant cognitive or behavioral impairment (see Research Strategy for testing and exclusions) or pharmacological treatment for this (e.g. antipsychotics, anxiolytics, and sedative medications).
* Hormone replacement therapy, past 3 months.
* Hyper-androgenic condition.
* HbA1C≥7.5% and or Fasting plasma glucose concentration ≥130 mg/dL.
* Type 2 Diabetes if receiving any other therapy than metformin.
* Use of nicotine or ingestion of caffeine or alcohol during the study.
* Habitual fat intake \< 25% of kcal or strict vegetarian diet.
* Sleep apnea requiring continuous positive airway pressure at night.
* Lung, cardiac (heart failure or its treatment), liver disease, renal disease, cancer, and any other medical disorder known or thought to cause inflammation or abnormalities of cognition
* Actively training for an athletic event or participating in competitive sports (such as league play or tournaments)
* Intolerance or allergy to any of the food provided in the study.

Where it's running

  • University of Vermont
    Burlington, Vermont, United States
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.